Fernandes MS, Melo S, Velho S, Carneiro P, Carneiro F, Seruca R

Specific inhibition of p110a subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers. Oncotarget 7: 68546-68558, 2016.  [Article] 

 doi: 10.18632/oncotarget.11843 PMID: 27602501.